Skip to main content
. Author manuscript; available in PMC: 2015 Mar 13.
Published in final edited form as: AIDS. 2014 Mar 13;28(5):739–743. doi: 10.1097/QAD.0000000000000150

Fig 2.

Fig 2

Low level CVL HIV RNA in three different phenotypic groups. (a) CVL HIV RNA in representative viremic subjects off HAART. (b) Elite controllers compared to HAART suppressors. (c) Logitudinal evaluation of CVL HIV RNA in elite controllers and HAART suppressors.

1T1, T2, T3: the start, middle, and end visit of phenotypic period respectively